Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

BZ-26, A Novel GW9662 Derivate, Attenuated Inflammation By Inhibiting The Differentiation And Activation Of Inflammatory Macrophages.

Yuncheng Bei, J. Chen, F. Zhou, Yahong Huang, N. Jiang, R. Tan, P. Shen
Published 2016 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Peroxisome proliferator-activated receptor-gamma (PPARγ) is considered to be an important transcriptional factor in regulation of macrophages differentiation and activation. We have synthesized a series of novel structural molecules based on GW9662's structure (named BZ-24, BZ-25 and BZ-26), and interaction activity was calculated by computational docking. BZ-26 had shown stronger interaction with PPARγ and had higher transcriptional inhibitory activity of PPARγ with lower dosage compared with GW9662. BZ-26 was proved to inhibit inflammatory macrophage differentiation. LPS-induced acute inflammation mouse model was applied to demonstrate its anti-inflammatory activity. And the results showed that BZ-26 administration attenuated plasma tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) secretion, which are vital cytokines in acute inflammation. The anti-inflammatory activity was examined in THP-1 cell line, and TNF-α, IL-6 and MCP-1, were significantly inhibited. The results of Western blot and luciferase reporter assay indicated that BZ-26 not only inhibited NF-κB transcriptional activity, but also abolished LPS-induce nuclear translocation of P65. We also test BZ-26 action in tumor-bearing chronic inflammation mouse model, and BZ-26 was able to alter macrophages phenotype, resulting in antitumor effect. All our data revealed that BZ-26 modulated LPS-induced acute inflammation via inhibiting inflammatory macrophages differentiation and activation, potentially via inhibition of NF-κB signal pathway.
This paper references
10.1038/cddis.2013.141
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
D. Vara (2013)
10.1016/j.tem.2012.05.001
PPARs at the crossroads of lipid signaling and inflammation
W. Wahli (2012)
10.1038/83336
PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
Ajay Chawla (2001)
10.1038/nri3070
Monocyte recruitment during infection and inflammation
C. Shi (2011)
10.1038/nri3520
Macrophages in atherosclerosis: a dynamic balance
Kathryn J. Moore (2013)
10.1016/j.immuni.2014.06.010
Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy (2014)
10.4049/jimmunol.0901196
Fos Proteins Suppress Dextran Sulfate Sodium-Induced Colitis through Inhibition of NF-κB
Y. Takada (2009)
10.1038/sj.bjp.0705973
GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation
J. Seargent (2004)
10.1021/JM030065N
Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
S. Kamath (2003)
10.1016/j.cell.2010.01.025
Immunity, Inflammation, and Cancer
S. Grivennikov (2010)
10.1007/s11010-015-2514-z
The role of PPARγ in TBBPA-mediated endocrine disrupting effects in human choriocarcinoma JEG-3 cells
Ewelina Honkisz (2015)
10.1007/s00109-006-0113-x
The roles of endogenous reactive oxygen species and nitric oxide in triptolide-induced apoptotic cell death in macrophages
Xiaofeng Bao (2006)
10.1016/j.immuni.2008.03.002
Cytokine signaling modules in inflammatory responses.
J. O'Shea (2008)
10.1016/j.tem.2012.03.001
Thiazolidinediones and PPARγ agonists: time for a reassessment
B. Cariou (2012)
10.1038/sj.bjc.6602603
ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
A. Ryan (2005)
10.1016/j.cmet.2013.11.001
Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation.
X. Xu (2013)
10.1016/S0165-6147(00)01559-5
PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
G. Murphy (2000)
5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid.
C. Clerici (1998)
10.1016/S1043-2760(02)00668-9
Peroxisome proliferator-activated receptor-γ in macrophage lipid homeostasis
C. Lee (2002)
10.1016/S1471-4906(02)02302-5
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
A. Mantovani (2002)
10.1016/J.IT.2007.09.003
Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.
D. Straus (2007)
10.2337/db12-0868
Reduced Adipose Tissue Macrophage Content Is Associated With Improved Insulin Sensitivity in Thiazolidinedione-Treated Diabetic Humans
S. Koppaka (2013)
10.1038/nature03988
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
G. Pascual (2005)
10.1152/AJPENDO.00255.2001
Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart.
A. Kanazawa (2002)
10.1055/S-0037-1613360
Allelic discrimination of factor V Leiden using the GeneAmp 5700 Sequence Detection System.
S. Monk (2002)
10.1021/JM050623T
Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate.
M. Yamada (2005)
10.1189/jlb.1106672
Catalase potentiates retinoic acid‐induced THP‐1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator‐activated receptor γ
Qiurong Ding (2007)
10.1189/jlb.0613326
Rosiglitazone‐induced CD36 up‐regulation resolves inflammation by PPARγ and 5‐LO‐dependent pathways
I. Ballesteros (2014)
10.1016/S0304-3835(98)00165-7
Activation of NF-κB mediates the PMA-induced differentiation of K562 cells
C. Kang (1998)
10.1021/BI0159581
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.
L. Leesnitzer (2002)
10.1038/ni.2705
Tissue-resident macrophages
Luke C Davies (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar